|
CTTT |
Interim CEO Certificate - 1st Quarter September 30, 2024 |
Autre |
07/02/2025 |
 Open Filing (115.43 Ko) |
|
JIVA |
Report of Exempt Distribution |
Autre |
07/02/2025 |
Open Filing (1.55 Mo) |
|
CTTT |
Interim MD&A - 1st Quarter September 30, 2024 |
MD & A (Discussion et analyse de la direction) |
07/02/2025 |
Open Filing (268.77 Ko) |
|
CTTT |
Interim Financial Statements - 1st Quarter September 30, 2024 |
États financiers intermédiaires |
07/02/2025 |
Open Filing (356.98 Ko) |
|
JIVA |
Report of Exempt Distribution |
Autre |
07/02/2025 |
Open Filing (1.55 Mo) |
|
CTTT |
Form 5 - 1st Quarter September 30, 2024 |
Déclaration d'inscription trimestrielle |
07/02/2025 |
Open Filing (625.5 Ko) |
|
HEAL |
Restart Life Sciences Corp. Relies on Exception Under CSE Policy 4.6(2)(b) for Previously Closed Private Placement and Debt Settlement Transactions and Announces Debt Settlement Transaction |
Communiqué de presse |
07/02/2025 |
Open Filing (78.49 Ko) |
|
CTTT |
Annual CFO Certificate for YE June 30, 2024 |
Autre |
07/02/2025 |
Open Filing (114.98 Ko) |
|
ETR |
Monthly Progress Report-Jan 2025 |
Rapport d'activité mensuel |
07/02/2025 |
Open Filing (176.23 Ko) |
|
CTTT |
Annual CEO Certificate for YE June 30, 2024 |
Autre |
07/02/2025 |
Open Filing (115.58 Ko) |
